These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29982783)

  • 1. Foreword: clinical challenges of diagnosing and managing giant cell arteritis.
    Stone JH
    Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii1-ii2. PubMed ID: 29982783
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocilizumab (Actemra) for giant cell arteritis.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):161-162. PubMed ID: 28922343
    [No Abstract]   [Full Text] [Related]  

  • 3. Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
    Sadun A; Gordon L
    J Neuroophthalmol; 2020 Mar; 40(1):117-121. PubMed ID: 31834197
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory giant cell arteritis on prednisone and tocilizumab: improvement with subsequent tuberculosis reactivation.
    Kherani I; Chin C; Kherani RB; Kherani F
    Can J Ophthalmol; 2019 Aug; 54(4):e192-e194. PubMed ID: 31358167
    [No Abstract]   [Full Text] [Related]  

  • 5. The Treatment of Giant Cell Arteritis in Different Clinical Settings.
    Pfeil A; Oelzner P; Hellmann P
    Front Immunol; 2018; 9():3129. PubMed ID: 30733723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.
    Seror R; Baron G; Hachulla E; Debandt M; Larroche C; Puéchal X; Maurier F; de Wazieres B; Quéméneur T; Ravaud P; Mariette X
    Ann Rheum Dis; 2014 Dec; 73(12):2074-81. PubMed ID: 23897775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2017; 106(22):1251-1252. PubMed ID: 29088969
    [No Abstract]   [Full Text] [Related]  

  • 8. Takayasu arteritis and NYHA III/IV idiopathic cardiomiopathy: tocilizumab proves effective and safe.
    Schiavon F; Cuffaro S; Ometto F; Mojoli M; Ramonda R
    Joint Bone Spine; 2014 May; 81(3):278-9. PubMed ID: 24388783
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis.
    Beyer C; Axmann R; Sahinbegovic E; Distler JH; Manger B; Schett G; Zwerina J
    Ann Rheum Dis; 2011 Oct; 70(10):1874-5. PubMed ID: 21515917
    [No Abstract]   [Full Text] [Related]  

  • 10. Giant cell arteritis: new concepts, treatments and the unmet need that remains.
    Coath F; Gillbert K; Griffiths B; Hall F; Kay L; Lanyon P; Luqmani R; Mackie SL; Mason JC; Mills J; Mollan S; Morgan AW; Mukhtyar C; Quick V; Watts R; Dasgupta B
    Rheumatology (Oxford); 2019 Jul; 58(7):1123-1125. PubMed ID: 30423174
    [No Abstract]   [Full Text] [Related]  

  • 11. Embouchure Claudication: A Trumpeter's Unique Presentation of Giant Cell Arteritis.
    Chenevey RE; Afkhamnejad ER; Martin TJ
    J Neuroophthalmol; 2019 Dec; 39(4):498-499. PubMed ID: 31790373
    [No Abstract]   [Full Text] [Related]  

  • 12. Tocilizumab for the treatment of giant cell arteritis.
    Schirmer M; Muratore F; Salvarani C
    Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Temporal arteritis as a cause of a terrible headache].
    Wiszniewska M; Wiszniewski P; Breborowicz J
    Neurol Neurochir Pol; 1999; 33(2):461-4. PubMed ID: 10463259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachial plexopathy as a presenting symptom of giant cell arteritis.
    Chowdhry IA; Sinha J; Barland P
    J Rheumatol; 2002 Dec; 29(12):2653-7. PubMed ID: 12465169
    [No Abstract]   [Full Text] [Related]  

  • 15. Giant cell arteritis and bilateral peroneal nerve palsy.
    Edvardsson B; Eriksson B
    Scand J Rheumatol; 2010 May; 39(3):269-70. PubMed ID: 20059406
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis.
    Ann Intern Med; 2007 May; 146(9):I12. PubMed ID: 17470826
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and emerging diagnosis tools and therapeutics for giant cell arteritis.
    González-Gay MA; Pina T; Prieto-Peña D; Calderon-Goercke M; Blanco R; Castañeda S
    Expert Rev Clin Immunol; 2018 Jul; 14(7):593-605. PubMed ID: 29877748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large artery giant cell arteritis: a diagnosis to remember.
    Caramaschi P; Biasi D; Carletto A; Zeminian S; Manzo T; Bambara LM
    Clin Rheumatol; 1997 Mar; 16(2):219-20. PubMed ID: 9093809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuropathy of the common peroneal nerve caused by giant cell arteritis].
    Tomasina C; Manzino M
    Minerva Cardioangiol; 1996 Nov; 44(11):595-9. PubMed ID: 9011841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
    Krüger K
    Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.